Results 171 to 180 of about 619,857 (348)

Identification of the Cytokines, Growth Factors and Their Receptors Expressed by Human Blood Eosinophils: A Transcriptomics Approach

open access: yes
Clinical &Experimental Allergy, EarlyView.
Stephane Esnault   +10 more
wiley   +1 more source

Lung organoids as a human system for Mycobacteria infection modeling and drug testing

open access: yesThe FEBS Journal, EarlyView.
Mycobacterial infections, including tuberculosis (TB) and infections by nontuberculous mycobacteria (NTM), are still public health issues. In 2023, TB caused 1.25 million deaths, while NTM remain a clinical challenge for patients with cystic fibrosis (CF).
Stephen Adonai Leon‐Icaza   +4 more
wiley   +1 more source

Reassessing the Relationship Between Exhaled Nitric Oxide and Acute Bronchodilation in Asthma Patients

open access: yes
Clinical &Experimental Allergy, EarlyView.
Martin Färdig   +6 more
wiley   +1 more source

Overlapping forms of granulomatosis with polyangiitis and eosinophilic granulomatosis with polyangiitis: Insights from a European multicenter study

open access: yesJournal of Internal Medicine, EarlyView.
Abstract Background Granulomatosis with polyangiitis (GPA) and eosinophilic granulomatosis with polyangiitis (EGPA) are distinct forms of antineutrophil cytoplasm antibody (ANCA)‐associated vasculitis (AAV). Increasing evidence suggests overlapping features, particularly in proteinase 3 (PR3)‐ANCA‐positive EGPA and GPA with eosinophilia.
Federica Pallotti   +45 more
wiley   +1 more source

Analysis of CCR2 chemokine receptor gene polymorphism in patients with bronchial asthma and chronic obstructive pulmonary disease

open access: hybrid, 2013
И. И. Черкашина   +7 more
openalex   +2 more sources

Type‐2 Biomarkers, Asthma Diagnosis and Lung Function Impairment in the General Population

open access: yes
Clinical &Experimental Allergy, EarlyView.
Sebastian Riemann   +2 more
wiley   +1 more source

Efficacy and safety of zuranolone in Japanese adults with major depressive disorder: A double‐blind, randomized, placebo‐controlled, Phase 3 clinical trial

open access: yesPsychiatry and Clinical Neurosciences, EarlyView.
Aim To evaluate the efficacy and safety of oral zuranolone for 14 days, compared with placebo, in Japanese patients with major depressive disorder (MDD). Methods This multicenter, Phase 3 study was conducted in two parts (70 sites; Japan) including a randomized, double‐blind, placebo‐controlled, parallel‐group part presented herein.
Masaki Kato   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy